Table 4.

Change in Glycemic and Patient-Reported Outcomes Among CGM Users by Baseline BGM Frequency in the REPLACE Study: ≥4 vs <4 Tests/Day. ¹⁰²

	BGM change from baseline		Adjusted mean change from baseline		Difference in adjusted means	P value
	BGM frequency/day		BGM frequency/day
	≥4 (n = 90)	<4 (n = 59)	≥4 (n = 90)	<4 (n = 59)
HbA1c (%)	−0.21	−0.37	−0.29	−0.24	−0.05	.6891
%Time < 70 mg/dL (%)	−3.44	−2.23	−3.01	−2.90	−0.11	.8497
%Time < 55 mg/dL (%)	−1.77	−1.53	−1.63	−1.73	0.10	.7012
Number of hypos < 70 mg/dL	−0.32	−0.19	−0.27	−0.26	−0.01	.9050
Number of hypos < 55 mg/dL	−0.20	−0.18	−0.18	−0.22	0.04	.3222
Treatment satisfaction	13.54	13.65	13.42	13.48	−0.06	.9444

Abbreviations: CGM, continuous glucose monitoring; BGM, blood glucose monitoring; HbA1c, glycated hemoglobin.